Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Freeze dried combination of Lansoprazole available for linjection and preparation method

A technology of lansoprazole and composition, applied in the field of proton pump inhibitors, can solve the problems of reduced drug efficacy, less production batch and high production cost, and achieve the effects of reducing production cost, increasing production batch and improving product quality

Inactive Publication Date: 2005-08-31
龙蓓
View PDF0 Cites 31 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It can be seen from this that the use of meglumine as a stabilizer component results in less production batches, high production costs, and it is difficult to ensure product quality. Although high-precision filters can be used in injections to avoid harm to the human body, crystals Reduced dosage after being filtered makes the drug less effective

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0008] Components and content of the present invention can be realized in the following examples (parts by weight):

[0009] 1. Lansoprazole 30, sodium hydroxide 5.6, arginine 15, water 0.5.

[0010] 2. Lansoprazole 35, sodium hydroxide 3, histidine 12, mannitol 0.5, sodium chloride 1.5, water 0.3.

[0011] 3. Lansoprazole 38, sodium hydroxide 7, lysine 20, water 0.8.

[0012] 4. Lansoprazole 45, sodium hydroxide 10, arginine 22, water 1.5.

[0013] 5. Lansoprazole 32, sodium hydroxide 5, histidine 18, lactose 3, water 0.3.

[0014] 6. Lansoprazole 38, sodium hydroxide 8, arginine 22, water 1.

[0015] 7. Lansoprazole 50, sodium hydroxide 15, histidine 40, lactose 1.8, mannitol 100, water 8.

[0016] 8. Lansoprazole 55, sodium hydroxide 20, lysine 45, glucose 120, water 8.

[0017] 9. Lansoprazole 60, sodium hydroxide 20, arginine 50, mannitol 150, water 8.5.

[0018] 10. Lansoprazole 30, sodium hydroxide 5.5, arginine 30, mannitol 70, water 0.5.

[0019] 11. Lansoprazo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A freeze-dried powder injection of lansoprazole is prepared from lansoprazole, cosolvent, alkaline amino acid and water proportionally.

Description

technical field [0001] The invention relates to a proton pump inhibitor, which is an injectable freeze-dried composition mainly composed of lansoprazole and a preparation method thereof. Background technique [0002] Lansoprazole has been publicly used as a medicinal ingredient, and the common dosage forms are tablets, capsules, etc., and there are also very few freeze-dried powder injections. Because it adopts meglumine as the stabilizing agent in the freeze-dried powder component, and the structure of meglumine only contains a basic group, although there is a certain buffering power, it is not strong enough to make lansoprazole injection Precipitation and crystallization will occur within 4 hours of the prepared medicinal solution at room temperature. And the crystallization amount that lansoprazole occurs in the injection is one of the most important indicators of quality control in production. In production, from the coarse filtration of liquid preparation, the determin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/19A61K31/4439A61P1/04
Inventor 朱贵云李广起
Owner 龙蓓
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products